Effect of non‐operative management (NOM) of splenic rupture versus splenectomy on the distribution of peripheral blood lymphocyte populations and cytokine production by T cells

Post‐traumatic splenectomy is associated with increased postoperative morbidity and mortality and long‐term impairment of humoral and cellular immunity. Alternatives to surgery have been developed to minimize or avoid the immediate and/or long‐term complications of splenectomy. Herein we investigated the long‐term effect of non‐operative management (NOM) of the traumatic rupture of the spleen on the distribution of peripheral blood (PB) lymphocyte populations and cytokine production by T cells. PB samples were drawn from six NOM patients, 13 age‐matched adults who had undergone splenectomy after trauma (SP patients) and 31 age‐matched controls. Cellular phenotypes and the intracellular production of interferon (IFN)‐γ, interleukin (IL)‐2, IL‐4 and IL‐10 cytokines in T cells were determined in whole blood ± mitogens by flow cytometry. NOM patients did not show any changes in the absolute numbers of lymphocytes or the distribution of their subsets, compared to the controls. In contrast, SP patients showed a sustained increase in the percentage and/or absolute numbers of lymphocytes, CD8 T cells, activated CD8 T cells, natural killer (NK) T cells, NK cells and γδ T cells, and a reduction in naive CD4 T cells. The constitutive or induced cytokine production by T cells of the NOM group was similar to the control group, whereas SP patients had increased percentages of constitutive IL‐2‐ and IFN‐γ‐producing CD8 T cells and IFN‐γ‐producing CD4 T cells. Our findings indicate collectively that the healing process in NOM does not affect the architecture of the spleen to such an extent that it would lead to long‐term alterations of the proportions of PB lymphocytes or the T cell cytokine profiles.

[1]  R. Gamelli,et al.  Immunologic Responses to Critical Injury and Sepsis , 2006, Journal of intensive care medicine.

[2]  M. Humbert,et al.  Splenectomy and chronic thromboembolic pulmonary hypertension , 2005, Thorax.

[3]  M. Björkholm,et al.  A prospective study on antibody response to repeated vaccinations with pneumococcal capsular polysaccharide in splenectomized individuals with special reference to Hodgkin's lymphoma , 2004, Journal of internal medicine.

[4]  K. Schroder,et al.  Interferon- : an overview of signals, mechanisms and functions , 2004 .

[5]  C. Vagianos,et al.  In Vitro Study of the Long‐Term Effects of Post‐Traumatic Splenectomy on Cellular Immunity , 2004, Scandinavian journal of immunology.

[6]  S. Romero-Steiner,et al.  Antibody responses in postsplenectomy trauma patients receiving the 23-valent pneumococcal polysaccharide vaccine at 14 versus 28 days postoperatively. , 2002, The Journal of trauma.

[7]  W. Timens,et al.  The dual function of the splenic marginal zone: essential for initiation of anti‐TI‐2 responses but also vital in the general first‐line defense against blood‐borne antigens , 2002, Clinical and experimental immunology.

[8]  M. Lowdell,et al.  Use of Leu3a/3b for the accurate determination of CD4 subsets for measurement of intracellular cytokines. , 2001, Cytometry.

[9]  T. Seabrook,et al.  Splenectomy selectively affects the distribution and mobility of the recirculating lymphocyte pool. , 2000, Blood.

[10]  S. Uranüs,et al.  Long‐term decrease of CD4+CD45RA+ T cells and impaired primary immune response after post‐traumatic splenectomy , 1999, British journal of haematology.

[11]  Pabst Regeneration of autotransplanted splenic fragments: basic immunological and clinical relevance , 1999, Clinical and experimental immunology.

[12]  W. Timens,et al.  Spleen autotransplantation provides restoration of functional splenic lymphoid compartments and improves the humoral immune response to pneumococcal polysaccharide vaccine , 1999, Clinical and experimental immunology.

[13]  W. Timens,et al.  Immune response capacity after human splenic autotransplantation: restoration of response to individual pneumococcal vaccine subtypes. , 1999, Annals of surgery.

[14]  I M Bain,et al.  10 year experience of splenic injury: an increasing place for conservative management after blunt trauma. , 1998, Injury.

[15]  S. Romero-Steiner,et al.  Immune responses of splenectomized trauma patients to the 23-valent pneumococcal polysaccharide vaccine at 1 versus 7 versus 14 days after splenectomy. , 1997, The Journal of trauma.

[16]  K. Sharp,et al.  Efficacy and safety of pneumococcal revaccination after splenectomy for trauma. , 1995, The Journal of trauma.

[17]  V. Maino,et al.  Direct demonstration of cytokine synthesis heterogeneity among human memory/effector T cells by flow cytometry. , 1995, Blood.

[18]  H. Champion,et al.  Organ injury scaling. , 1995, The Surgical clinics of North America.

[19]  M. Álvarez-Mon,et al.  Persistent lymphocytosis of natural killer cells in autoimmune thrombocytopenic purpura (ATP) patients after splenectomy , 1995, British journal of haematology.

[20]  H. Champion,et al.  Organ injury scaling: spleen and liver (1994 revision). , 1995, The Journal of trauma.

[21]  G. Modin,et al.  Transfusion significantly increases the risk for infection after splenic injury. , 1993, Archives of surgery.

[22]  F. Carbonell-Tatay,et al.  Cellular immunity in splenectomized patients. , 1991, Journal of investigational allergology & clinical immunology.

[23]  M. Capra,et al.  CD69 in resting and activated T lymphocytes. Its association with a GTP binding protein and biochemical requirements for its expression. , 1991, Journal of immunology.

[24]  H. E. Heier,et al.  IgG Subclass Antibody Responses to Pneumococcal Polysaccharide Vaccine in Splenectomized, Otherwise Normal, Individuals , 1990, Scandinavian journal of immunology.

[25]  R. Schwinzer,et al.  Lymphocyte Subsets in the Blood , 1990, Scandinavian journal of immunology.

[26]  Winfred C. Wang,et al.  Lymphocyte and complement abnormalities in splenectomized patients with hematologic disorders , 1988, American journal of hematology.

[27]  R. Satava,et al.  Comparison of omental splenic autotransplant to partial splenectomy. Protective effect against septic death. , 1987, The American surgeon.

[28]  H. Zola,et al.  Peripheral blood leucocyte subpopulations in patients splenectomized for trauma. , 1987, Clinical and experimental immunology.

[29]  R. Zubler,et al.  The interleukin 2 secretion defect in vitro in systemic lupus erythematosus is reversible in rested cultured T cells. , 1986, Journal of immunology.

[30]  T. Linné,et al.  IgG and IgM Antibody Responses to Pneumococcal Vaccination in Splenectomized Children and in Children Who Had Non‐Operative Management of Splenic Rupture , 1986, Acta paediatrica Scandinavica.

[31]  A. Ferrante,et al.  Elevated natural killer (NK) cytotoxicity of mononuclear leucocytes from splenectomized patients: increase in Leu-7+ and Leu-11+ leucocytes. , 1986, Clinical and experimental immunology.

[32]  C. Scott-Conner,et al.  Methods of Splenic Preservation and Their Effect on Clearance of Pneumococcal Bacteremia , 1985, Annals of surgery.

[33]  P. Drew,et al.  Lack of effect of splenic regrowth on the reduced antibody responses to pneumococcal polysaccharides in splenectomized patients. , 1985, Clinical and experimental immunology.

[34]  G. Sieber,et al.  Abnormalities of B-cell activation and immunoregulation in splenectomized patients. , 1985, Immunobiology.

[35]  M. Malangoni,et al.  Factors influencing the risk of early and late serious infection in adults after splenectomy for trauma. , 1984, Surgery.

[36]  G. Zlabinger,et al.  Peripheral blood mononuclear cells of splenectomized patients are unable to differentiate into immunoglobulin-secreting cells after pokeweed mitogen stimulation. , 1984, Clinical immunology and immunopathology.

[37]  A. Ferrante,et al.  Alterations in immunoglobulin synthesis by peripheral blood mononuclear cells from splenectomized patients with and without splenic regrowth. , 1984, Journal of immunology.

[38]  G. Moore,et al.  Failure of splenic implants to protect against fatal postsplenectomy infection. , 1983, American journal of surgery.

[39]  M. Frank,et al.  IMPAIRED IMMUNE RESPONSE OF SPLENECTOMISED PATIENTS TO POLYVALENT PNEUMOCOCCAL VACCINE , 1981, The Lancet.

[40]  W. Haddon,et al.  The injury severity score: a method for describing patients with multiple injuries and evaluating emergency care. , 1974, The Journal of trauma.

[41]  C. Sillaber,et al.  Antibody responses to pneumococcal and hemophilus vaccinations in splenectomized patients with hematological malignancies or trauma , 2006, Wiener klinische Wochenschrift.

[42]  S. Uranüs,et al.  Nonoperative Treatment of Blunt Splenic Injury , 2001, World Journal of Surgery.

[43]  J. Demeter,et al.  Observations on NK cells, K cells and on their function a long time after posttraumatic splenectomy. , 1990, International archives of allergy and applied immunology.

[44]  J. Hassett,et al.  Immune consequences of nonoperative treatment of splenic trauma in the rat model. , 1989, Journal of pediatric surgery.